HRMY
Harmony Biosciences Holdings
$41.10
−$0.52 (−1.25%)Sep 10, 2026
Key metrics
The numbers that frame HRMY today
- Market cap
- $2.39B
- P/E (TTM)
- 13.2
- EV / FCF
- 5.6
- Gross margin
- 75.4%
- EV / Sales
- 2.1
- ROIC
- 52%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $25.52
- 52wk High
- $43.49
Growth
Revenue and earnings trend for HRMY
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HRMY
Is Harmony Biosciences Holdings a good buy?
Yes. Harmony Biosciences Holdings has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Harmony Biosciences Holdings is selling at a low price.
What is the market capitalization of HRMY?
Harmony Biosciences Holdings's market capitalization is $2.39B.
What is the P/E ratio for HRMY stock?
Harmony Biosciences Holdings's current P/E ratio is 13.2.
What is the 52-week high for HRMY stock?
The 52-week high for Harmony Biosciences Holdings is $43.49. The current close of $41.10 is 5.5% below that high.
What is the 52-week low for HRMY stock?
The 52-week low for Harmony Biosciences Holdings is $25.52. The current close of $41.10 is 61.1% above that low.
Does HRMY stock pay dividends?
Harmony Biosciences Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HRMY?
Harmony Biosciences Holdings's Debt / Equity ratio is 0.15.